Viewing nowLaminaphin Tablets (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
The U Pharmaceutical Co., Ltd.

MFDS item code 201501740 · Approved 2015.03.31 · Insurance code 057000340
Treatment of onychomycosis, dermatomycoses (e.g., tinea pedis and tinea corporis), and tinea capitis
This medication is used in adults for the treatment of dermatophyte infections caused by fungi, including athlete's foot, ringworm, and onychomycosis. In children, it is effective for treating tinea capitis. In other words, it helps treat fungal infections that occur on the skin and nails.
1. Adults Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment varies according to the condition, as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris (jock itch): 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. For infections of the fingernails or relatively small toenails, or in younger patients, the treatment duration may be shortened to 3 months or less. For toenail infections, 3 months of treatment is usually sufficient, although some patients may require 6 months or longer. Treatment may take longer in patients with slow nail growth. 3. Patients with renal impairment For patients with a creatinine clearance of less than 50 mL/min, reduce the daily dose by 1/2.
2. Children: Administer to children aged 2 years and older. Administration is not recommended in children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of the infection, treatment should be given regularly and for the prescribed duration. 1) Body weight under 20 kg (under 5 years): Administer 62.5 mg per dose, once daily. Because there is limited experience with its use, the decision to administer should be made after considering the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg per dose, once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg per dose, once daily.
This medication is not recommended for patients with chronic liver disease or active liver disease. Regular liver function tests should be conducted before and during treatment, and the medication should be discontinued immediately if symptoms of liver dysfunction appear. Patients suspected of having liver dysfunction or damage should consult a doctor promptly, as serious side effects such as liver failure can occur rarely. Do not take this medication if there is a hypersensitivity reaction, blood disorders, severe renal failure, in infants under 2 years old, lactating women, or patients with certain genetic lactose intolerance. Patients with decreased kidney function, the elderly, children weighing less than 20 kg, and those with skin conditions should use this medication cautiously, and if serious skin reactions occur, the medication should be discontinued immediately. This medication can cause various side effects; if symptoms such as nausea, vomiting, fatigue, rash, myalgia, headache, visual impairment, etc., occur, notify healthcare professionals immediately. Be cautious while driving or operating machinery, as dizziness and other symptoms may occur. If taken with other medications, interactions may occur, so all medications being taken should be reported to a doctor or pharmacist, and dosage adjustments may be necessary. Women who are pregnant or may become pregnant should be cautious when using this medication, and breastfeeding women should discontinue breastfeeding during treatment. In case of overdose, symptoms such as headache, nausea, abdominal pain, dizziness may occur, and if these symptoms appear, visit the hospital immediately. Keep this medication out of reach of children and store it at room temperature away from direct sunlight.
Liver failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, malaise, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous hemorrhage, leukopenia, anemia, rash, itching, photosensitivity reaction, skin and mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, vesicular dermatitis, psoriatic rash, worsening of psoriasis, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, elevated myoglobin, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasis, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, discomfort in the upper abdomen, thirst, vomiting, glossitis, depression, anxiety disorder, headache, taste disturbance, dizziness, drowsiness, sensory abnormalities, decreased sensation, decreased attention, insomnia, elevated BUN, polyuria, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol in the blood, elevated triglycerides, malaise, discoloration of the tongue, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, reduced vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, anosmia, hyposmia, drug rash with eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
The U Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.